News in Brief

Published: 1-Mar-2003


  • Bristol-Myers Squibb has agreed to pay US$670m (€626m) to settle numerous lawsuits after it was accused of using illegal tactics to keep lower-priced versions of its medicines, cancer-fighting Taxol and the anti-anxiety drug BuSpar, out of the market for many months. Both drugs are now available as generic medicines.

  • The EU has initiated formal talks ; the first stage of disputes proceedings at the World Trade Organisation ; over import restrictions imposed by the Indian government on a range or products including penicillin, its salts, and derivatives, rifampicin, streptomycins or their derivatives, and first aid boxes or kits.

  • The European Agency for the Evaluation of Medicinal Products (EMEA) has announced that the EU marketing authorisation for hepatitis B treatment Hepacare has been withdrawn by the European Commission. The decision followed manufacturer Celltech Pharmaceuticals' commercial decision to abandon plans to sell the medicine. Alternative vaccines are available in Europe.

  • An EU-funded research project has identified four strains of lactobacilli that could help treat intestinal inflammations and infections. The aim of the Deprohealth scheme, which has received €1.4m ($1.5m) in Brussels money; is to develop oral probiotic bacteria vaccines to counter conditions such as rotavirus, which causes infant diarrhoea, and Crohn's disease. Participating researchers from France, Italy, Belgium, Spain, the UK and Australia have had to identify strains that not only prevented inflammation, but also could withstand human digestive acids.

  • A US federal judge has ruled that an approval letter with a delayed effective date given by the FDA should be considered merely a tentative approval and does not give a manufacturer the legal right to begin marketing a medicine. The judge was ruling against Barr Laboratories' bid to market a generic version of tamoxifen tablets, which the company had expected to release last August. He quashed a bid by Barr to overturn FDA restrictions on selling a product ahead of its release. The FDA had stressed that Barr should wait until the original patent currently held by AstraZeneca had expired.
    See more

    • You may also like

    Manufacturing

    Reliable detection for high-temperature processes

    Read more
    ifm has launched the LMH point level sensor, a robust solution engineered for reliable medium detection in demanding industrial environments

    Trending Articles

    1. Destination Russia for new NYK Logistics warehouse <p>Logistics specialist NYK is expanding its market presence with the launch of new warehousing operation in Moscow, Russia.</p>
    2. Piramal Pharma Solutions’ Grangemouth facility successfully delivers 1500th ADC batch With this achievement, Piramal strengthens its leadership position in delivering critical bioconjugate therapies to patients in need
    3. From powder to granules: a deep dive into wet granulation methods - WEBINAR NOW ON DEMAND Join ACG in partnership with Manufacturing Chemist for an expert-led session to explore how different wet granulation methods impact consistency, yield, and quality — and what really matters when it comes to selecting and optimising your process
    4. Viatris to cut 10% of its global workforce after Indian plant fire Viatris has lowered its profit outlook for 2026 after a fire in February shut down a key plant in Nashik, India. Despite this, the company reported stronger-than-expected revenue and announced a restructuring plan
    5. Amcor’s Winterbourne site achieves ISO 13485 certification, strengthening its position and capabilities in healthcare ISO 13485:2016 is an internationally recognised quality management standard specifically for medical devices.

    Upcoming event

    Cleanroom Technology Awards 2026

    13 April | Virtual     See all

    You may also like

    Manufacturing

    Reliable detection for high-temperature processes

    ifm has launched the LMH point level sensor, a robust solution engineered for reliable medium detection in demanding industrial environments
    Manufacturing

    Nulogy launches Supplier Compliance Management to build stronger, more resilient supplier networks

    Nulogy, a leading provider of manufacturing operations software, announced the launch of Nulogy Supplier Compliance Management, a solution designed to centralise and automate supplier compliance for procurement, supply chain, and quality assurance teams in manufacturing, food & beverage, pharmaceuticals, and other highly regulated industries
    Manufacturing

    Huber: Leading suppliers of world-class thermoregulation solutions

    Since 1968, Huber has been at the forefront of technological advancement and continuous innovation in the field of liquid temperature control
    Manufacturing

    Hugo Beck launches sleeve wrapper for sustainable transport packaging

    New paper S machine provides practical alternative to plastic and cardboard
    Regulatory

    TurboFil debuts latest generation of through-the-tip benchtop syringe filler

    TipFil Plus provides precise, aseptic-ready filling and capping for lab and pharmacy applications
    Manufacturing

    Concentrating recombinant proteins for drug discovery using centrifugal evaporation

    Exploring purification, concentration and sample protection in recombinant protein workflows
    Research & Development

    COVID-19 immunity lowers the risk of a new pandemic

    Researchers at the MRC-University of Glasgow Centre for Virus Research have demonstrated that the likelihood of the emergence of a new SARS-type virus pandemic has been significantly reduced by population-wide immunity to SARS-CoV-2
    Subscribe now